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The objective of this study was to assess knowledge regarding the health effects and 
nutrient content of nuts and perceptions regarding benefits and barriers of nut intake among 
individuals over the age of 40 years.  One hundred cross-sectional surveys were gathered from 
two sites in Greenville, NC. Eighty-five of the surveys collected met the inclusion criteria, 
Caucasian or African American ethnicity and above 40 years of age.  The mean age of the 
participants was 63 and 77.6% were Caucasian, while the other 22.4% were African American. 
            About one-third of the participants were previously diagnosed with diabetes. Also, two-
thirds of participants were previously diagnosed with some type of cardiovascular disease 
(CVD): heart disease (61.4%), heart attack (56.4%), angina (51.8%), and stroke (50.0%).  
Approximately 40% of individuals were not aware that nuts could help lower the risk for heart 
attacks or diabetes.  Only about one-eighth of the participants were aware of the predominant fat 
found in nuts.  Approximately 27% strongly agreed or agreed that their doctors had advised them 
to eat nuts most days of the week.  However, 63% strongly agreed or agreed that they would 
consume nuts most days of the week if their doctor made these recommendations.  Beliefs and 
perceptions were inadequate and knowledge levels were low.  This indicates that current 
scientific evidence is not being conveyed to individuals with or at risk of CVD and/or diabetes. 
  
Education regarding health benefits of nuts provided by doctors and other healthcare 
professionals could help reduce CVD and/or diabetes incidences and mortalities. 
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 CHAPTER 1: REVIEW OF SCIENTIFIC LITERATURE  
Introduction 
 Cardiovascular disease (CVD), a disease of the heart and blood vessels, is the leading 
cause of mortality in the United States (Albert, Gaziano, Willett & Manson, 2002; What is 
cardiovascular disease, 2011).  The risk for developing CVD increases with age.  Females have 
higher mortality rates due to CVD than males; CVD claimed about 51.8% of female lives in 
2007.  Mortality rates from CVD have decreased by 27.8% from 1997 to 2007, due in part to 
medical developments; yet the burden of CVD still remains high.  In the United States, heart 
disease accounted for 831,804 (33.6% of total deaths) deaths in 2007 and approximately 
82,600,000 individuals have at least one type of CVD (Rogers et al., 2011). 
Association of Nut Intake with Cardiovascular Disease 
In 1992, Fraser, Sabaté, Beeson, and Strahan published the first study reporting reduced 
risk for coronary heart disease (CHD) related to frequent nut intake.  Since then, more than 200 
studies, including large prospective studies as well as many interventional studies, have been 
published reporting a beneficial impact of nut consumption on many chronic diseases.  Most of 
these studies have dealt with risk factors for CVD; such as cholesterol level, blood lipid level, 
and inflammation.  This beneficial impact of nuts on CVD is likely due to the nutritional profile 
of nuts. 
Nut Consumption 
Tree nuts are defined as a dried fruit with hardened ovarian walls when matured and 
contain a single seed.  Different types of common tree nuts are almonds, hazelnuts, walnuts, 
pecans, macadamia nuts, pistachios, pine nuts, cashews, chestnuts, coconuts, and Brazil nuts 
(USDA, n.d.; Ros, 2010).  Peanuts are botanically classified as legumes; yet are commonly 
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categorized in the nut food group by consumers (Ros, 2010).  For the purpose of this study, 
peanuts will be categorized by the consumer classification.  Nut intake has been increasing over 
the years.  In the 1980-1981 season, 1.82 pounds of nuts were consumed per capita in the United 
States.  However, during the 2009-2010 season, 3.69 pounds of nuts were ingested per person, as 
shown in Table 1 (USDA, n.d.).  This is significantly low in comparison to the current nut intake 
recommendation of 1.5 ounces (24 pounds) (FDA, 2009).  It is unclear whether this increase in 
nut consumption is due to the growing number of studies that have uncovered the benefits from 
nut consumption. 
Table 1. 2009-2010 nut consumption per capita 
Nuts 1980-1981 2009-2010 
Almonds 0.42 1.40 
Hazelnuts 0.05 0.05 
Pecans 0.43 0.45 
Walnuts 0.50 0.55 
Macadamias 0.07 0.10 
Pistachios 0.05 0.18 
Brazil Nuts, Pine Nuts, Chestnuts, Cashews, & Mixed Nuts 0.32 0.96 
Total  1.82 3.69 
(USDA, n.d.) 
 
Nutritional Profile of Nuts 
Nuts are a nutrient dense food (Ros, 2010).  Most nuts are a good source of protein, 
monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA).  They are also 
relatively low in saturated fatty acids (SFA) and contain no trans fatty acids or cholesterol 
(Chisholm, McAuley, Mann, Williams, & Skeaff, 2005; Ros 2010).  The exception includes 
chestnuts that contain very little fat and coconuts that contain mainly SFA.  The consumption of 
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nuts can be used to replace foods higher in SFA, while at the same time provide beneficial 
MUFA and PUFA; which is consistent with the 2010 Dietary Guidelines for Americans (Dietary 
guidelines for Americans 2010, 2010; Griel et al., 2008).  The fat content of nuts is listed in 
Table 2.  Nuts also contain other nutrients and non-nutrient compounds that can help reduce the 
risk of CVD.  Such compounds include antioxidants such as vitamin E and selenium, minerals 
such as magnesium, and amino acids such as L-arginine.  Nuts also contain phytochemicals such 
as phenolic compounds, plant sterol and plant stenols (Jenkins et al., 2008; Ros, 2010).  
Table 2. Fat content of nuts per 100 g 
Nuts SFA (g) MUFA (g) PUFA (g) 
Almonds 3.7 30.9 12.1 
Brazil Nuts 15.1 24.5 20.6 
Cashews 7.8 23.8 7.8 
Hazelnuts 4.5 45.7 7.9 
Macadamia Nuts 12.1 58.9 1.5 
Peanuts 6.8 24.4 15.6 
Pecans 6.2 40.8 21.6 
Pine Nuts 4.9 18.8 34.1 
Pistachios 5.6 23.8 13.7 
Walnuts 6.1 8.9 47.2 
 
US Department of Agriculture Nutrient Database, n.d. 
 
Prospective Studies on Benefits of Nut Intake 
Fraser et al. (1992) evaluated the association of food consumption and chronic diseases, 
which included nut intake and CHD.  This cohort study included 31,208 non-Hispanic white, 
Seventh-Day Adventists from California, with a mean age of 52 years.  Researchers found a 
decrease of 48% in definite non-fatal myocardial infarction (MI) and 38% decrease in definite 
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fatal CHD in individuals who consumed nuts more than five times a week in comparison to those 
with an intake of less than once a week.  Lower rates of definite non-fatal MI and definite fatal 
CHD were also seen in individuals who consumed wheat bread in comparison to white bread.  
However, the consumption of beef at least three times a week had a positive correlation in 
definite fatal CHD for both males and females, and a positive association in definite non-fatal MI 
for only males (Fraser et al., 1992).  
 Kushi et al. (1996) conducted a cohort study on 34,486 postmenopausal women, aged 55-
69 years.  The women had not been previously diagnosed with CVD and results were used to 
determine whether dietary antioxidant intake influenced CHD mortality.  Adjustments for age, 
total energy intake, body mass index (BMI), waist-to-hip ratio, smoking, history of diabetes and 
hypertension, oral-contraceptive use, estrogen-replacement therapy, physical activity, alcohol 
intake, marital status, and education level were made.  After adjustments were made, women 
who consumed nuts more than four times a week had a reduction of 40% in CHD death risk 
when compared to women who did not consume nuts.  When vitamin E was ingested through 
food consumption only, not supplementation, a decrease in CHD death risk was seen (Kushi et 
al., 1996).    
Hu et al. (1998) studied the association between nut intake and CHD risk in 86,016 
women from the Nurses’ Health Study.  The age of these women ranged from 34 to 59 years.  At 
baseline, only 102 individuals who consumed nuts more than five days a week reported having 
diabetes, compared to 747 individuals who never consumed nuts.  Researchers found a 39% 
decrease in fatal CHD risk, 32% risk decrease in non-fatal MI, 35% decrease in total CHD risk, 
and a 57% risk decrease in diabetes in women who consumed one ounce of nuts more than five 
times a week in comparison to those who consumed one ounce of nuts less than once a month.  
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These results were apparent after adjustments for age, smoking, and other known risk factors for 
CHD were made.  Similar results were seen when smoking, alcohol intake, multivitamin use, 
vitamin E supplementation, BMI, physical activity and intake of fruits and vegetables were 
adjusted (Hu et al., 1998). 
The Cholesterol and Recurrent Events Study (CARE) was conducted to look at the 
relationship between nuts and reoccurring CHD events.  The study included 3,575 
hypercholesterolemic individuals, aged 21-75 years, who had previously experienced non-fatal 
MI.  When nuts were consumed more than once a week, in comparison to less than once a 
month, there was a 25% reduction in total CHD risk.  These results were seen when age, 
smoking, and other known CHD risk factors were adjusted.  Adjustments for SFA, fiber, fruits, 
vegetables, minerals, and antioxidants did not significantly change the results (Kelly & Sabaté, 
2006). 
 Albert et al. (2002) evaluated the effects of nuts on CHD among 21,454 male physicians, 
40-84 years of age.  When calculating the results, adjustments for age, aspirin, beta carotene 
treatment assignment, CVD evidence 12 months prior to questionnaire, BMI, smoking, history of 
diabetes, history of hypertension or high blood pressure, alcohol intake, physical activity, 
vitamin E or C supplementation, and multivitamin use were made.  Also, dietary adjustments for 
fish, red meat, fruit, vegetable, and diary intake were made.  Researchers found that males who 
consumed nuts more than twice a week had a 30% decrease in fatal CHD risk when compared to 
those who consume nuts less than once a month.  A negative association was also seen in sudden 
cardiac death risk, but was not seen in non-fatal MI risk.  A 16% risk reduction in sudden cardiac 
death occurred in males who consumed nuts more than twice a month in comparison to less than 
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once a month.  A risk reduction of 40% in sudden cardiac death when nuts were consumed once 
a week and a 47% risk reduction when nuts were consumed more than twice a week when 
compared to less than once a week (Albert et al., 2002).  
Jiang and colleagues (2002) conducted the first large prospective cohort study on the 
association between nut intake and the risk of developing type 2 diabetes.  The study consisted of 
18,818 women from the Nurse’s Health Study, aged 34-59 years.  During the study, 3,206 new 
cases of diabetes were recorded.  There was strong evidence that the consumption of nuts and 
peanut butter were inversely associated with the risk of type 2 diabetes.  The nut consumption 
multivariate relative risk decreased by 27% when nuts were consumed more than five times a 
week and decreased by 21% when peanut butter was consumed more than five times a week, in 
comparison to never/almost never.  This relationship was seen after adjustments for age, BMI, 
history of diabetes, physical activity, alcohol intake, smoking, and total energy intake (Jiang et 
al., 2002).   
Djoussé, Rudich and Gaziano (2008) evaluated the relationship between heart failure and 
nut consumption in lean and overweight/obese individuals.  The study was conducted on 20,976 
males who took part in the Physicians’ Health Study I, with a mean age of 54.6 years.  When 
compared to participants with no intake of nuts, the multivariate adjusted hazard ratio for nut 
intake of less than once a week was 0.98, 1.06 for intake of once a week, and 1.01 for intake of 
more than two times a week.  Adjustments for age, smoking, BMI, heart disease, history of 
diabetes or hypertension, history of high blood pressure, alcohol consumption, multivitamin use 
fruit and vegetable intake, and exercise were made.  Once these adjustments were made, there 
was no direct association between heart failure and nut consumption in overweight/obese or lean 
individuals (Djoussé, Rudich & Gaziano; 2008) 
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Villegas and colleagues (2008) evaluated the association between soy food and total 
legumes (peanuts, lentils, beans, peas, and soybeans) consumption with self-reported type 2 
diabetes.  This prospective cohort study examined 64,227 middle-aged Chinese women.  There 
was a 38% decrease in the multivariate relative risk for type 2 diabetes when 3.1 g/day of total 
legumes were consumed when compared to the consumption of 0.1 g/day of total legumes.  An 
inverse association was seen between type 2 diabetes incidences and legume consumption in pre- 
and postmenopausal women when age, BMI, waist-to-hip ratio, total energy, fiber, vegetable 
intake, income level, education level, physical activity, smoking, history of hypertension, and 
occupation adjustments were made (Villegas et al., 2008). 
Djoussé and colleagues (2009) assessed the impact of nut intake on hypertension risk 
among 15,966 participants from the Physicians’ Health Study I.  The participants had a mean age 
of 52.3 years that ranged from 40.7-87.1.  Participants were not previously diagnosed with 
hypertension.  Nut consumption was more prevalent in individuals who drank coffee, took a 
multivitamin, and consumed fish, red meat, diary, and breakfast cereal.  The adjustments for age, 
BMI, smoking, alcohol intake, breakfast cereal consumption, red meat intake, fish intake, dairy 
consumption, exercise, fruit and vegetable intake, multivitamin use, treatment assignment, and 
history of diabetes, high blood pressure or high cholesterol were made.  The multivariable 
adjusted hazard ratio for hypertension was decreased by 3%, 2%, 4%, and 18% when nuts were 
consumed one to two times a month, once a week, two to six times a week, and more than seven 
times a week, respectively, when compared to no intake of nuts (Djoussé, Rudich & Gaziano; 
2009).  
The prospective studies reviewed above, with one exception, revealed consistent results 
that frequent nut consumption has been associated with a decrease in CVD and type 2 diabetes 
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(Fraser et al., 1992; Kushi et al., 1996; Hu et al., 1998; Kelly & Sabaté, 2006; Albert et al., 2002; 
Djoussé et al., 2008; Djoussé et al., 2009; Jiang et al., 2002; Villegas et al., 2008).  A graphical 
summary of the impact of nuts on the risk of CHD death of four major prospective studies can be 
seen below in Figure 1.  
Figure 1. Nut consumption and risk of CHD death in prospective studies 
 
Adopted from: Ros, 2010 
In 2002, The International Tree Nut Council Nutrition Research and Education 
Foundation (INC NREF) asked for approval of a health claim, based on the studies described 
above and other studies.  The INC NREF requested that the United States Food and Drug 
Administration (FDA) qualifies nuts (both tree nuts and peanuts) for a health claim that could be 
used on food labels.  The FDA-approved health claim reads: “Scientific evidence suggests but 
does not prove that eating 1.5 ounces per day of most nuts [such as name of specific nut] as part 
of a diet low in saturated fat and cholesterol may reduce the risk of heart disease [See nutrition 
information for fat content]” (FDA, 2009; The International Tree Nut Council Nutrition 
Research & Education Foundation, 2003). 
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Figure 1. Results of prospective studies of nut consumption and risk of death from 
coronary heart disease. 
 
 
In the Nurses’ Health Study [41], nut intake could be subdivided between all tree nuts and peanuts 
and peanut butter. Consumption of peanut products was also associated with a decreased relative risk 
of CHD. Subjects who consumed peanuts two or more times per week had a relative risk of CHD of 
0.66 (CI, 0.46 to 0.94), while for other nuts the relative risk for consumption of two or more times per 
week was 0.79 (CI, 0.50 to 1.25). A recent report of the same study concerning a subgroup of 6309 
wom n with type-2 diabetes at baseline shows similar findings, as consumption of at least five 
servings per week of nuts or peanut butter (serving size, 28 g [1 ounce] for nuts and 16 g [1 
tablespoon] for peanut butter) was significantly associated with a lower risk of cardiovascular disease, 
with a relative risk of 0.56 (CI, 0.36 to 0.89) [44]. 
It must be underlined that in all these studies [1,41-44] the protective effect of nut consumption on 
total CHD or sudden cardiac death was independent of gender, age, body mass index, alcohol use, 
other nutritional characteristics or presence of cardiovascular risk factors. The dose-relationship 
between nut intake and incident CHD translates into an average 8.3 reduction for each weekly serving 
of nuts [15]. The consistency of findings in all studies points to a causal association between nut 
consumption and reduced CHD, indicating that nuts possibly are one of the most cardioprotective 
foods in the habitual diet. 
Since inflammation is a key process in atherogenesis, one mechanism by which nut consumption 
may decrease CHD risk is by improving inflammatory status, which can be ascertained from levels of 
circulating inflammatory markers. Three cross-sectional studies have investigated nut consumption in 
relation to circulating inflammatory biomarkers [45-47]. In an analysis of data from nearly 6000 
participants in the Multi-Ethnic Study of Atherosclerosis (MESA) [45], consumption of nuts and seeds 
was inversely associated with levels of inflammatory markers, C-reactive protein (CRP), interleukin-6 
(IL-6) and fibrinogen. Another study of 987 diabetic women from the prospective Nurses’ Health 
Study [46] showed a direct association between nut consumption and increased plasma levels of 
adiponectin, an adipose tissue-secreted cytokine with antiinflammatory and antiatherosclerotic 
properties. The third study was carried out in 772 older subjects at high risk for CHD living in Spain 
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Effect of Nut Intake on Cardiovascular Disease Risk Factors 
According to the American Heart Association (AHA), the major risk factors of CVD 
include high blood pressure, high serum cholesterol, BMI, diabetes mellitus and smoking.  In 
2003, data from the Center of Disease Control Behavioral Risk Factor Surveillance System 
(CDC BRFSS) survey showed that as age increased, individuals were at a greater risk of having 
more than two CVD risk factors (Rogers et al., 2011).  Frequent intake of nuts appears to 
beneficially affect most dietary modifiable CVD risk factors.  
Nut Intake Effect on Blood Lipids 
In terms of reducing the risk for CVD, the primary beneficial effect nuts have is on 
altering blood lipid profiles (Chisholm et al., 2005).  Banel and Hu (2009), in a meta-analysis, 
reviewed 13 studies that assessed changes in the blood lipid profile using walnuts as an 
intervention.  Twelve of the studies were randomized trials and 10 had a crossover design.  
Between all 13 studies, 365 individuals were included. The subjects’ ages ranged from 25-75 
years and four of the studies consisted of only male subjects.  Four studies included individuals 
with healthy (as defined by author, no lipid-altering medications, or PSA >2.0 ng/mL) 
cholesterol levels and six studies only included individuals with modest hypercholesterolemia.  
The other three studies looked at the effects of walnut intake on people with type 2 diabetes, 
older obese individuals or individuals diagnosed with a metabolic syndrome.  In these studies, 
walnuts provided 10% and 24% of total calories.  The mean decrease in total cholesterol (TC) 
was 10.3 mg/dL and the mean decrease in low-density lipoprotein (LDL) cholesterol was 9.2 
mg/dL.  There was no significant difference seen in high-density lipoprotein (HDL) cholesterol 
or triglyceride (TG) levels when the control and walnut diets were compared (Banel & Hu, 
2009).  
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  Chisholm et al. (2005) conducted a study to determine the impact of nut intake on blood 
lipids of 28 healthy men and women with a mean age of 48.3 years.  Participants purchased their 
own nuts, which included almonds, Brazil nuts, cashews, hazelnuts, macadamia nuts, peanuts, 
pecans, pistachios, and walnuts.  The nuts were used as part of a low SFA diet that required 30 
g/day of nuts.  After consuming the experimental diet for two separate, six weeks periods, 
researchers found a decrease from 5.96 mmol/L to 5.44 mmol/L in TC and from 4.08 mmol/L to 
3.67 mmol/L in LDL cholesterol (Chisholm et al., 2005).  
Griel et al. (2008) also found that TC and LDL cholesterol levels were decreased due to 
the unsaturated fatty acid content in nuts.  This study consisted of 25 moderately, 
hypercholesterolemic males and females, with a mean age of 50.2 years.  One and a half ounces 
of macadamia nuts was added to each participants’ meals.  The addition of nuts to the meals 
resulted in a decrease in TC from 5.66 mmol/L to 4.94 mmol/L (9.4%) and a decrease in LDL 
cholesterol from 3.68 mmol/L to 3.14 mmol/L (8.9%) (Griel et al., 2008).  
Gebauer et al. (2008) conducted a study on pistachios and their effect on cholesterol 
levels in 28 males and females, with a mean age of 50.9 years.  Participants consumed a lower-
fat diet containing no pistachios, a one serving of pistachios diet, or two servings of pistachios 
diet.  The two servings of pistachios diet resulted in reduced LDL cholesterol by 11.6% and TC 
by 8%.  This study was the first study to indicate an inverse relationship between pistachios and 
CVD risk factors (Gebauer et al., 2008). 
Sabaté et al. (2010) looked at the effect of nut consumption on blood lipids by evaluating 
25 interventional studies.  Combined, the studies included 583 individuals from seven different 
countries who consumed a mean of 67 g of nuts daily.  A mean decrease of 10.9 mg/dL in TC, a 
mean decrease of 10.2 mg/dL in LDL cholesterol, and a mean increase of 0.009 in HDL 
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cholesterol was seen when nuts were consumed.  In individuals with TG levels greater than 150 
mg/dL at baseline, a 20.6 mg/dL decrease in TG levels was seen at the end of the study (Sabaté, 
Oda & Ros, 2010). 
The AHA estimates that a 10% decrease in TC levels could reduce CHD incidence by 
approximately 30% (Rogers et al., 2011).  Studies, as seen in Table 3, have shown that nut 
consumption could be used as a therapeutic dietary intervention to reduce blood lipid levels, 
including TC, LDL cholesterol and TG.  An increased frequency of nut consumption can result 
in a greater decrease in blood lipid levels, as seen above in Figure 2.  A reduction in blood lipid 
levels can help lower CVD risk (Chisholm et al., 2005; Banel & Hu, 2009; Griel et al., 2008; 
Gebauer et al., 2008; Sabaté et al., 2010). 
Figure 2. Effect of nut consumption on blood lipid and lipoprotein levels 
 
 
Adopted from: Sabaté et al., 2010 
 
Table 3. Change in blood lipid profiles in interventional nut studies Most important is the finding that the cholesterol-
lowering effects of nut consumption are dose related and
are more pronounced in subjects with higher baseline
LDL-C or lower BMI. Nut consumption also lowered tri-
glyceride levels in subjectswithhypertriglyceridemia. Study
design, type of funding source, and degree of dietary con-
trol did not significantly affect these outcomes. This study
provides the best estimate of the effects of nut consump-
tion on blood lipid levels. Specifically, a mean daily con-
sumptionof 67g (2.4oz)ofnuts resulted in estimatedmean
reductions of 10.9mg/dL (5.1%change) inTC, 10.2mg/dL
(7.4% change) in LDL-C, 0.22 (8.3% change) in ratio of
LDL-C to HDL-C, and 0.24 (5.6% change) in ratio of TC
to HDL-C. The estimated reductions in this pooled analy-
sis are almost identical to those obtained in a recent meta-
analysis39 ofwalnut consumption studies (−10.3mg/dL for
TC and −9.2 mg/dL for LDL-C). The similarity of the re-
sults obtained by different methodologic approaches con-
firms the validity of our findings.
While the blood lipid level and lipoprotein results cor-
roborate thoseofprevious clinical trials, theobservedeffect
of a nut diet!BMI interaction on blood lipid level re-
sponses is a novel finding. In agreement with this obser-
vation, Mukuddem-Peterson et al40 recently reported that
high consumption of neither walnuts nor cashewswas as-
sociated with blood lipid level changes in subjects with
obesity andmetabolic syndrome. It iswell established that
obese subjects have an attenuated cholesterol-lowering re-
sponse to dietary reduction of saturated fatty acids com-
paredwithleanindividuals,probablybecauseobesity ischar-
acterizedbyelevatedendogenousproductionof cholesterol
in relation to insulin resistance.41 However, in most of the
nut consumption trials inourpooledanalysis, nutdiets and
∗
∗
†
∗
∗
†
∗
†
∗
†
†
0
– 4
– 2
– 6
– 8
– 12
– 10
%
 C
ha
ng
e
A Baseline LDL-C concentration mg/dL
< 130 130-160 >  160
∗
∗
†
∗
∗
∗
†
†
∗
†
† †
0
– 4
– 2
– 6
– 8
– 12
– 10
TC LDL-C LDL-C/HDL-C TC/HDL-C TG
%
 C
ha
ng
e
B Baseline BMI
< 25 25-30 >  30
Figure 1. Estimated effects of nut consumption on blood lipid and
lipoprotein levels by baseline LDL-C concentration (A) and by baseline BMI
(B). *P" .001 and †P" .05 for difference between nut diet and control diet.
To convert cholesterol concentrations to millimoles per liter, multiply by
0.0259. BMI indicates body mass index (calculated as weight in kilograms
divided by height in meters squared); HDL-C, high-density lipoprotein
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TC, total cholesterol; and TG, triglycerides.
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Dietary intakes from nuts of 10%, 12.2%, and 20% are equivalent to 35, 43,
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Food and Drug Administration10; 12.2% is equivalent to 43 g/d (1.5 oz/d).
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Source 
# of 
Subjects 
(Sex) 
Mean 
Age, y 
Subject 
Characteristic 
Daily 
Amt of 
Nuts & 
Type, g 
Duration of 
Dietary 
Interventio
n, wk 
TC LDL HDL TG 
Sabaté et 
al., 1993, 
USA 
N=18 
(18M) 
Age: 30  
Normocholesterole
mia 
79 Walnut 4 -
12.4% 
-
16.3% 
-4.9% -8.3% 
Abbey et 
al., 1994, 
Australia 
N=16 
(16M) 
Age: 41 
Normocholesterole
mia 
84 
Almond, 
68 Walnut 
3 -7% & 
-5% 
-10% 
& -9% 
No 
significa
nt 
change 
No 
significa
nt 
change 
Colquhou
n et al., 
1996, 
Australia 
N=14 
(7M, 
7F) 
Age: 46 
Normocholesterole
mia 
54 
Macadam
ia 
4 -7.9% -
10.7% 
No 
significa
nt 
change 
-20.9% 
Spiller et 
al., 1998, 
Canada 
N=45 
(12M, 
33F) 
Age: 53 
Hypercholesterolem
ia 
100 
Almond 
4 -222 ± 
28 
mg/dL 
-141 ± 
25 
mg/dL 
No 
significa
nt 
changes 
No 
significa
nt 
changes 
Chisholm 
et al., 
1998, 
New 
Zealand 
N=16 
(16M) 
Age: 45 
Hypercholesterolem
ia 
78 Walnut 4 -0.25 
mmol/
L 
-0.36 
mmol/
L 
0.15 
mmol/L 
0.05 
mmol/L 
Kris-
Etherton 
et al., 
1999, 
USA 
N=22 
(9M, 
13F) 
Age: 
Unknow
n 
Normocholesterole
mia 
Unknown 
Peanut 
3.4 -10% -14% No 
significa
nt 
change 
-13% 
Edwards 
et al., 
1999, 
USA 
N=10 
(4M, 
6F) 
Age: 46 
Hypercholesterolem
ia 
60 
Pistachio 
3 -9 
mg/dL 
-11 mg 
% 
4 mg % -6 mg/dL 
Durak et 
al., 1999, 
Turkey 
N=30 
(18M, 
12F) 
Age: 
Unknow
n 
Normocholesterole
mia 
69 
Hazelnut 
4.3 -8 
mg/dL 
-14 
mg/dL 
3 mg/dL 19 
mg/dL 
Zambón 
et al., 
2000, 
Spain 
N=49 
(26M, 
23F) 
Age: 56 
Hypercholesterolem
ia 
46 Walnut 6 -4.1% -5.9% 3.2% -6.1% 
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Morgan 
& 
Clayshult, 
2000, 
USA 
N=19 
(4M, 
15F) 
Age: 41 
Normocholesterolemia 68 Pecan 8 -0.15 
mmol/L 
-0.15 
mmol/L 
0.08 
mmol/L 
-0.14 
mmol/L 
Curb et 
al., 2000, 
USA 
N=30 
(15M, 
15F) 
Age: 
Unknown 
Normocholesterolemia Unknown 
Macadamia 
4.3 -0.36 
mg/dL 
-0.25 
mg/dL 
-0.05 
mg/dL 
-0.12 
mg/dL 
Rajaram 
et al., 
2001, 
USA 
N=23 
(14M, 
9F) Age: 
38 
Normocholesterolemia 85 Pecan 4 -6.7% -10.4% 5.6% -11.1% 
Almario 
et al., 
2001, 
USA 
N=18 
(5M, 
13F) 
Age: 
Unknown 
Normocholesterolemia 52 Walnut 6 -0.58 ± 
0.16 
mmol/L 
(HD+W 
diet) & -
0.46 ± 
0.14 
mmol/L 
(LFD+W 
diet) 
-33.4 ± 
4.3 % 
(HD+W 
diet) 
-0.13 
mmol/L 
(HD+W 
diet) & -
0.16 
mmol/L 
(LFD+W 
diet) 
No 
significant 
change 
Lovejoy 
et al., 
2002, 
USA 
N=30 
(13M, 
17F) 
Age: 25 
Normocholesterolemia       
Lovejoy 
et al., 
2002, 
USA 
N=20 
(10M, 
10F) 
Age: 54 
Normocholesterolemia       
Jenkins et 
al., 2002, 
Canada 
N=27 
(15M, 
12F) 
Age: 64 
Hypercholesterolemia       
Iwamoto 
et al., 
2002, 
Japan 
N=40 
(20M, 
20F) 
Age: 24 
Normocholesterolemia 51 Walnut 4 -4.5% -9.8% -1.3% 0% 
Hyson et 
al., 2002, 
USA 
N=22 
(10M, 
12F) 
Age: 44 
Normocholesterolemia 66 Almond 6 -4% -6% 6% -14% 
 
Adopted & Modified from: Sabaté et al., 2010 
Nut Intake Effect on Hypertension 
Hypertension is one of the leading risk factors of CVD (Rogers et al., 2011).  
Hypertension currently affects approximately 1 billion individuals and results in about 7.6 
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million pre-mature deaths worldwide (Martínez-Lapiscina et al., 2010).  Diets containing nuts 
have shown to decrease systolic and diastolic blood pressure in men and women (Djoussé et al., 
2009).  Djoussé and colleagues (2009) illustrated the effects of nut consumption on hypertension 
in the prospective cohort study, Physicians’ Health Study I, mentioned earlier. 
 Martínez-Lapiscina et al. (2010) conducted a cohort study, known as Seguimiento 
Universidad de Navarra (SUN), on 9,919 Spanish graduates to evaluate the association between 
nut consumption and hypertension.  Individuals with prevalent hypertension prior to the study 
were excluded.  Incidence of hypertension was prevalent in only about 12 per 1,000 
persons/year.  Unlike Djoussé and colleagues (2009), Martínez-Lapiscina et al. (2010) found no 
significant relationship between nut consumption and hypertension once adjustments for sex, 
age, and other dietary and non-dietary factors were made; this may be due to a small risk of 
hypertension in the participants within the study.   
Nut Intake Effect on Inflammation 
Inflammation has developed into a risk factor for CVD and can be measured through 
circulatory inflammatory biomarkers (Jiang et al., 2006; Ros, 2010).  Plasma C-reactive protein 
(CRP), interleukin-6 (IL-6), fibrinogen, intercellular adhesion molecule-1 (ICAM-1) and E-
selectin are some commonly measured inflammatory biomarkers (Rajaram et al., 2010; Jiang et 
al., 2006; Mantzoro et al., 2006).  Nuts have anti-inflammatory properties, which can help reduce 
vascular inflammation (Jiang et al., 2006).   
Rajaram et al. (2010) conducted a randomized, controlled crossover study on 25 adults, 
with a mean age of 40.9 years. Participants consumed one of three diets: controlled diet with no 
nuts (< 30% energy from fat), low-almond diet (10% isoenergetic replacement with almonds) or 
high-almond diet (20% isoenergetic replacement with almonds).  A decrease in serum E-selectin 
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was seen as the consumption of almonds increased; as fat energy from almonds increased by 1%, 
E-selectin decreased by 0.18 µg/L.  Mean CRP decreased in low and high almond diets, 53.5 g/L 
and 50.1 g/L respectively, when compared to the controlled diet, 54.3 g/L (Rajaram, Connell & 
Sabaté, 2010). 
A study was conducted with 6,080 individuals with a mean age of 62.2 years (45-84 
years), who participated in the Multi-Ethnic Study of Atherosclerosis (MESA).  This study 
showed an inverse relationship between nut consumption and inflammatory biomarkers.  All 
biomarker levels were lower when a higher frequency of nuts was consumed.  The CRP level 
among participants who rarely/never consumed nuts was 1.98 mg/L.  When participants 
consumed nuts less than once a week was 1.97 mg/L, one to four times a week was 1.80 mg/L, 
and more than five times a week was 1.72 mg/L.  IL-6 levels for nut consumption of 
rarely/never, less than once a week, one to four times a week and more than five times a week 
was 343, 338, 338 and 331 mg/dL, respectively.  Also, fibrinogen levels for nut consumption of 
rarely/never, less than once a week, one to four times a week, and more than five times a week 
was 1.25, 1.24, 1.21 and 1.15 pg/mL, respectively (Jiang et al., 2006).     
Mantzoro (2006) conducted a study with 987 diabetic women between the ages of 30 and 
55.  The women had no known history of CVD and were from the Nurses’ Health Study. Levels 
of adiponectin were measured.  Adiponectin is adipose tissue with anti-inflammatory and anti-
atherosclerotic properties.  Women who consumed nuts had adiponectin levels 12% higher than 
those with a lower intake of nuts.   (Mantzoro et al., 2006).   
The studies reviewed above indicate an inverse association between nut intake and 
inflammation.  The relationship can be seen through a decrease in inflammatory biomarkers such 
as CRP, IL-6, fibrinogen, ICAM-1 and E-selectin (Rajaram et al., 2010; Jiang et al., 2006; 
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Mantzoro et al., 2006).  Mantzoro et al. (2006) found a positive correlation between nut intake 
and adiponectin; which also indicates an inverse relationship between nut consumption and 
inflammation.     
Conclusion 
Many studies have been conducted on the impact of tree nuts and peanuts on CVD and 
diabetes.  These studies showed beneficial effects in terms of a decrease in risk for diabetes 
and/or CVD incidences and deaths, and also decreasing CVD risk factors such as blood lipid 
profile and inflammation. Existing evidence indicates that best results can be achieved when nuts 
are consumed frequently.  
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CHAPTER 2: METHODOLOGY 
Study Rational 
 As indicated in chapter 1, nuts have a beneficial impact on the risk of CVD and/or 
diabetes incidences and mortalities.  Although more than 200 studies on the health impact of nuts 
have been conducted, studies on the assessment of the perceptions of health benefits of nuts are 
almost nonexistent.  Only two studies are currently present that have assessed beliefs, 
perceptions, and knowledge of health benefits concerning nut intake.   
Pawlak, Colby, and Herring (2009) conducted a study on a sample of WIC (women, 
infant, and children) participants and found that three-fourths of participants did not believe nuts 
could lower the risk for heart disease or diabetes.  In addition, two-thirds did not believe nuts 
could help lower cholesterol levels and slightly more than one-thirds believed nuts would cause 
weight gain.  Also, the awareness among participants was low in relation to the nutrient content 
of nuts.  Most importantly, this research concluded that WIC participants were in need of 
education regarding the health benefits of nut intake (Pawlak, Colby, & Herring, 2009).   
Pawlak (2009) also conducted a study on the perception, knowledge, and beliefs of 
dietitians regarding the health benefits of nut consumption and nutrient content of nuts. Pawlak 
found that the majority of participants were aware of the beneficial effects nuts have on lowering 
heart attack risk and cholesterol levels.  Many agreed that nuts were a good source of omega-3 
fatty acids and disagreed they contained too much fat.  Belief and perceptions were adequate and 
the knowledge questions were answered correctly among the majority of dietitians (Pawlak, 
2009). 
The awareness of the health benefits of nuts is unclear among people with or at risk for 
CVD and/or diabetes.  It is also unknown what other perceived beliefs, barriers, or attitudes 
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towards eating nuts are prevalent among people in this population.  Awareness, attitudes, beliefs, 
and perceived benefits and barriers are underlying factors for intention to engage in a behavior 
(Pawlak, 2003).  Therefore, the goal of this research is to assess the beliefs, perceptions (e.g. 
attitudes and perceived barriers and benefits), knowledge, and nut consumption of individuals 
over the age of 40 because they are at greater risk for developing diabetes and/or CVD (Rogers 
et al., 2011).    
Research Objectives 
The specific objectives of this research and the methods to achieve them include: 
Objective 1. Understand participants’ beliefs concerning health benefits and nutrient content of 
nuts.  Beliefs of participants were assessed using nine statements with three possible answers; 
true/agree, false/disagree and I don’t know, and the percentages were calculated.   
Table 4. Percentage of beliefs concerning nutrient content and health benefits of nuts 
Statements 
True/ 
Agree 
(%) 
False/ 
Disagree 
(%) 
I Don’t 
Know 
(%) 
Nuts are high in calories  
Nuts are high in fat  
Nuts are high in dietary fiber  
Nuts are high in salt  
Eating nuts may help to lower cholesterol level 
Eating nuts may help to lower a risk for a heart attack 
Eating nuts may help to lower a risk for diabetes 
Eating nuts will cause weight gain 
The U.S. Food and Drug Administration approved a health claim to 
say that eating nuts daily/on most days may lower cholesterol and 
prevent heart disease 
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Objective 2. Measure positive and negative attitudes towards nut intake.  Attitudes on nut intake 
were measured using ten attitudinal statements, five negative and five positive. The statements 
were scored on a Likert scale rated 1-strongly agree, 2-agree, 3-neither, 4-disagree, and 5-
strongly disagree and the distribution was calculated.  
Table 5. Distribution of statements concerning attitudes towards eating nuts on most days of a 
week 
Positive/negative attitude statements 
1 
Strongly 
Agree 
2 
Agree 
3 
Neither 
4 
Disagree 
5 
Strongly 
Disagree 
(%) (%) (%) (%) (%) 
Negative attitude 
I should not eat nuts on most days of a week 
because they are high in fat  
I should not eat nuts on most days of a week 
because they are high in salt 
I should not eat nuts on most days of a week 
because they would cause my cholesterol to 
increase  
I should not eat nuts on most days of a week 
because I would gain weight 
I should not eat nuts on most days of a week 
because nuts cause allergies 
Positive attitude 
I should eat nuts on most days of a week 
because nuts are healthy 
I should eat nuts on most days of a week 
because nuts are high in nutrients  
I should eat nuts on most days of a week 
because nuts are high in protein 
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Positive/negative attitude statements 
1 
Strongly 
Agree 
2 
Agree 
3 
Neither 
4 
Disagree 
5 
Strongly 
Disagree 
(%) (%) (%) (%) (%) 
I should eat nuts on most days of a week 
because nuts are filling 
I should eat nuts on most days of a week 
because nuts are a good source of omega-3 
fat 
 
Objective 3. Evaluate perceived benefits and barriers to eating nuts.  Benefits and barriers of nut 
intake were evaluated with 17 statements, eight benefit and nine barrier questions. The 
statements were scored on a Likert scale rated 1-strongly agree, 2-agree, 3-neither, 4-disagree, 
and 5-strongly disagree and the distribution was calculated. 
Table 6. Distribution of statements concerning benefits and barriers to eating nuts on most days 
of a week 
Benefits and barrier statements 
1 
Strongly 
Agree 
2 
Agree 
3 
Neither 
4 
Disagree 
5 
Strongly 
Disagree 
(%) (%) (%) (%) (%) 
Benefits 
Eating nuts on most day of a week would 
help me feel better 
Eating nuts on most days of a week would 
help me to take better care of my body  
Eating nuts on most days of a week would 
help me get more nutrients 
Eating nuts on most days of a week would 
help me be healthier 
Eating nuts on most days of a week would 
give me the energy I need 
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Benefits and barrier statements 
1 
Strongly 
Agree 
2 
Agree 
3 
Neither 
4 
Disagree 
5 
Strongly 
Disagree 
(%) (%) (%) (%) (%) 
Eating nuts on most days of a week would 
help me to eat more fiber 
Eating nuts on most days of a week would 
help me to look young 
Eating nuts on most days of a week would 
be consistent with the advice of my doctor 
Barriers 
Eating nuts on most days of a week would 
cost me too much money  
Eating nuts on most days of a week would 
cause me to eat too much fat 
Eating nuts on most days of a week would 
cause me to eat too many calories  
I would eat nuts on most days of a week if 
they were available in grocery stores 
where I go shopping  
I would eat nuts on most days of a week if 
they were affordable 
I would eat nuts on most days of a week if 
they had more flavor 
I would eat nuts on most days of a week if 
they were lower in fat 
I would eat nuts on most days of a week if 
they were lower in calories 
I would eat nuts on most days of a week if 
my doctor recommended me to do so 
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Objective 4. Assess knowledge regarding the nutrient content of nuts.  Knowledge of participants 
was assessed with five multiple-choice questions with the choice of four to eight answers. The 
percentage correct for each question was calculated. 
Table 7. Percentage of correctly answered knowledge questions related to the nutrient content of 
nuts 
Knowledge Questions Correct 
Answers (%) 
Nuts such as almonds, pecans, macadamia nuts, cashews and/or hazelnuts 
contain mainly which of the following type of fat?  
Walnuts contain mainly which of the following fat? 
Peanuts and walnuts are considered a good source of which of the following 
fats? 
Which of the following nuts have the highest content of omega-3 fatty acids? 
Which of the following nuts have the highest content of selenium?  
 
 
Objective 5. Estimate the consumption of nuts in individuals with or at risk for CVD and/or 
diabetes.  Individuals were given five choices to estimate their nut intake; never, less than once a 
month, 1-2 times a month, once a week, and 1-2 times a week and the distribution was 
calculated. 
Survey 
 A survey was adopted and modified from Pawlak and colleagues (2009).  A registered 
dietitian, Mary Gaskins, who works with CVD and respiratory patients at the Cardiovascular and 
Pulmonary Rehabilitation and The Heart Failure Clinic at HealthSteps, reviewed the survey and 
modifications were made based her comments to adjust the reading level of the survey.  For 
example, the phrase “predominant fats” was changed to “mainly contains which of the following 
type of fat” to keep wording as simplistic as possible.  The survey included demographic 
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information, health information, estimated nut consumption, and assessed the beliefs, 
perceptions, and knowledge of the health effects of frequent nut consumption.  
The demographic data on the survey included: age, gender, ethnicity, weight, height, 
annual income level, and education level.  The health information on the survey included 
previously diagnosed diseases and age of diagnosis.  The survey included nine belief statements 
with three possible answers; true/agree, false/disagree and I don’t know.  The barriers and 
benefits of nut intake were evaluated using nine barrier and eight benefit statements that were 
scored on a Likert scale rated 1-strongly agree, 2-agree, 3-neither, 4-disagree, and 5-strongly 
disagree.  The Likert scale was also used for the 10 attitudinal statements, five positive and five 
negative.  Five knowledge questions were asked with four or eight answers to choose from.  
Lastly, four questions regarding nut consumption were asked with five to eight options to choose 
from.  
Survey Validation 
 The adopted and modified survey included nine belief (Cronbach’s Alpha = 0.742), five 
negative attitude (Cronbach’s Alpha = 0.823), five positive attitude (Cronbach’s Alpha = 0.848), 
eight benefit (Cronbach’s Alpha = 0854), and nine barrier (Cronbach’s Alpha = 0.703) 
statements about the health benefits and nutrient content regarding nut intake.  A reliability 
analysis of the knowledge variables was not conducted because each knowledge statement was 
treated as a separate measure of awareness of participants rather than collectively as a variable 
score.  The attitude, benefit, and barrier statements were scored on a Likert scale rated 1-strongly 
agree, 2-agree, 3-neither, 4-disagree, and 5-strongly disagree.  The belief statements could be 
answered as true/agree, false/disagree, or I don’t know and the knowledge multiple choice 
questions contained four to eight answers to choose from. 
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Participants 
 A total of 100 respondents initially participated.  However, only 85 participants met the 
inclusion criteria, which included Caucasian or African American ethnicity and greater than 40 
years of age.  The participants were purposively collected from the East Carolina Heart Institute 
and the Cardiovascular and Pulmonary Rehabilitation and The Heart Failure Clinic at 
HealthSteps in Greenville, North Carolina.  
Statistical Analysis 
 The percentage of true/agree, false/disagree, and I don’t know was calculated for the 
belief variables and the percentage answers on a 5-point Likert scale were calculated for the 
benefits, barriers, and attitude variables.  The percent correct was calculated for the knowledge 
questions and the distribution was calculated for various ways to consume nuts.  SPSS statistical 
software, 18th edition (SPSS, Inc., Chicago, IL 2008) was used for all data analysis.   
Data Collection 
From May 2011 to August 2011, surveys were administered to assess the beliefs, 
perceptions, and knowledge of the health benefits and nutrient content regarding nut 
consumption.  The study was approved the by the University and Medical Center Institutional 
Review Board at East Carolina University.  A consent form was read aloud and attached to each 
survey.  Participants were kept anonymous and were asked not to sign or print their name on the 
survey or consent form.  By filling out the survey, participants indicated they agreed to 
participate in the study.  It was clear that participation was voluntary and questions may be left 
unanswered.  The survey was distributed by William Bogey MD, RTV, FACS at East Carolina 
Heart Institute; and by a Mary Gaskins MS, RD, LDN at Cardiovascular and Pulmonary 
Rehabilitation and The Heart Failure Clinic at HealthSteps.
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CHAPTER 3: RESULTS 
 
Survey Results 
 A total of 100 surveys were collected from the East Carolina Heart Institute and the 
Cardiovascular and Pulmonary Rehabilitation and The Heart Failure Clinic at HealthSteps in 
Greenville, North Carolina.  Fifteen of these surveys were excluded because they did not meet 
the inclusion criteria.  Therefore, 85 surveys (85%) remained and were included in the analysis.   
Demographics 
 The mean age of the 85 participants was 63 years and ranged from 41 to 89 years.  
Participants’ gender was almost evenly distributed, 51.8% males and 48.2% females.  The 
majority of the participants were Caucasian (77.6%), while the remaining 22.4% were African 
American.  The mean BMI of the participants was 30.3.  Table 8 contains characteristics of the 
participants. 
Table 8. Study characteristics of participants 
Socio-demographic characteristics N % Valid 
(%) 
Age 
     Mean 
BMI 
     Mean  
     Missing 
Gender 
     Males 
     Females 
Ethnic Background 
     African American 
     Caucasian 
 
63 
 
30.4 
4 
 
44 
41 
 
19 
66 
 
 
 
 
 
 
51.8 
48.2 
 
22.4 
77.6 
 
 
 
 
 
 
51.8 
48.2 
 
22.4 
77.6 
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Socio-demographic characteristics N % Valid 
(%) 
Annual Household Income  
     <10,000 
     10,000-20,000 
     20,001-35,000 
     35,001-50,000 
     50,001-65,000 
     65,001-85,000 
     >85,000 
     Missing 
Highest Attained Education Level 
     Less than high school 
     Graduated from high school or completed the GED 
     Some college 
     Graduated college 
 
6 
8 
11 
15 
10 
12 
13 
10 
 
10 
21 
24 
30 
 
7.1 
9.4 
12.9 
17.6 
11.8 
14.1 
15.3 
11.8 
 
11.8 
24.7 
28.2 
35.3 
 
8.0 
10.7 
14.7 
20.0 
13.3 
16.0 
17.3 
- 
 
11.8 
24.7 
28.2 
35.3 
 
Disease Diagnosis or Risk Factors 
 Out of the 85 participants, 83.6% indicated they were previously diagnosed with at least 
one of the following: heart disease, heart attack, angina, stroke, hypertension, high cholesterol, or 
diabetes.  Out of these participants, 47.1% indicated they were previously diagnosed with heart 
disease, 27.1% had a heart attack, 11.8% with angina, 15.3% had a stroke, 61.2% with 
hypertension, 56.5% with high cholesterol, and 34.1% with diabetes.  Additional data can be 
reviewed in Table 9.  The majority of these respondents were Caucasian (76.1%) and males 
(67.4%).  Additionally, 54.2% of participants were diagnosed with at least one type of CVD 
(heart disease, heart attack, angina, and stroke), 30.6% with at least two types, 14.1% with at 
least three types, and 2.4% with all four types of CVD.  All the participants diagnosed with some 
type of CVD received their diagnosis between 50 and 60 years of age.  
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Table 9. Percentage of participants previously diagnosed with CVD and/or diabetes 
Disease Yes (%) No (%) 
I Don’t 
Know 
 (%) 
Missing 
(%) 
Heart Disease 
Heart Attack 
Angina 
Stroke 
Hypertension 
High Cholesterol 
Diabetes 
47.1 
27.1 
11.8 
15.3 
61.2 
56.5 
34.1 
35.3 
44.7 
52.9 
47.1 
21.2 
25.9 
40.0 
0 
1.2 
1.2 
1.2 
1.2 
1.2 
0 
17.6 
27.1 
34.1 
36.5 
16.5 
16.5 
25.9 
 
Beliefs 
 As shown in Table 10, about two-thirds of the participants believed that nuts were high in 
calories (64.7%), fat (68.2%), and dietary fiber (69.4%).  About 32% were unaware of the 
hypocholesterolemic effects of nuts and an additional 21% disagreed that nuts exhibit such 
effects.  Slightly more than one-third of respondents were unaware that frequent nut intake 
decreases the risk for heart attacks (38.8%) and about 17% disagreed that nuts could perform 
these effects.  Nearly 44% of the participants thought nuts were high in salt, while 10% were 
unsure of the salt content of nuts. Approximately 42% of the respondents were uninformed of the 
beneficial effects tree nuts and peanuts have on diabetes.  The majority (51.8%) was not aware 
that the FDA had approved a health claim indicating that the daily consumption of nuts would 
help lower cholesterol levels and prevent heart disease. 
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Table 10. Percentage of beliefs concerning nutrient content and health benefits of nuts 
 
Statements 
True/ 
Agree 
(%) 
False/ 
Disagree 
(%) 
I Don’t 
Know 
(%) 
Missing 
(%) 
Nuts are high in calories  
Nuts are high in fat  
Nuts are high in dietary fiber  
Nuts are high in salt  
Eating nuts may help to lower cholesterol level 
Eating nuts may help to lower a risk for a heart 
attack 
Eating nuts may help to lower a risk for diabetes 
Eating nuts will cause weight gain 
The U.S. Food and Drug Administration 
approved a health claim to say that eating nuts 
daily/on most days may lower cholesterol and 
prevent heart disease 
64.7 
68.2 
69.4 
43.5 
41.2 
41.2 
 
34.1 
34.1 
40.0 
21.2 
20.0 
5.9 
43.5 
21.2 
17.6 
 
20.0 
52.9 
5.9 
12.9 
10.6 
22.4 
10.6 
32.9 
38.8 
 
42.4 
10.6 
51.8 
1.2 
1.2 
2.4 
2.4 
4.7 
2.4 
 
3.5 
2.4 
2.4 
 
Attitudes 
 At least one-third of the participants strongly disagreed with all five negative attitudinal 
statements.  As seen in Table 11, about one-third of the participants strongly agreed, agreed, or 
neither agreed nor disagreed with the statement, “I should not eat nuts on most days of the week 
because I would gain weight.”  At least half of the participants strongly agreed or agreed with all 
five positive attitudinal statements.  One-third of participants neither agreed nor disagreed with 
the statements, “I should eat nuts on most days of a week because nuts are filling” and “I should 
eat nuts on most days of a week because nuts are a good source of omega-3 fat” (28.2% and 
38.8%, respectively).   
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Table 11. Distribution of statements concerning attitudes towards eating nuts on most days of a 
week 
Positive/negative attitude 
statements 
1 
Strongly 
Agree 
2 
Agree 
3 
Neither 
4 
Disagree 
5 
Strongly 
Disagree 
Missing 
(%) (%) (%) (%) (%) (%) 
Negative attitude 
I should not eat nuts on most 
days of a week because they 
are high in fat  
I should not eat nuts on most 
days of a week because they 
are high in salt 
I should not eat nuts on most 
days of a week because they 
would cause my cholesterol to 
increase  
I should not eat nuts on most 
days of a week because I 
would gain weight 
I should not eat nuts on most 
days of a week because nuts 
cause allergies 
Positive attitude 
I should eat nuts on most days 
of a week because nuts are 
healthy 
I should eat nuts on most days 
of a week because nuts are 
high in nutrients  
 
8.2 
 
 
8.2 
 
 
5.9 
 
 
 
4.7 
 
 
7.1 
 
 
 
48.2 
 
 
47.1 
 
 
 
11.8 
 
 
15.3 
 
 
10.6 
 
 
 
12.9 
 
 
4.7 
 
 
 
23.5 
 
 
25.9 
 
 
 
23.5 
 
 
23.5 
 
 
28.2 
 
 
 
16.5 
 
 
21.2 
 
 
 
12.9 
 
 
15.3 
 
 
 
21.2 
 
 
21.2 
 
 
23.5 
 
 
 
36.5 
 
 
20.0 
 
 
 
7.1 
 
 
5.9 
 
 
 
35.3 
 
 
31.8 
 
 
30.6 
 
 
 
29.4 
 
 
47.1 
 
 
 
7.1 
 
 
2.4 
 
 
 
- 
 
 
- 
 
 
1.2 
 
 
 
- 
 
 
- 
 
 
 
1.2 
 
 
3.5 
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Positive/negative attitude 
statements 
1 
Strongly 
Agree 
2 
Agree 
3 
Neither 
4 
Disagree 
5 
Strongly 
Disagree 
Missing 
(%) (%) (%) (%) (%) (%) 
I should eat nuts on most days 
of a week because nuts are 
high in protein 
I should eat nuts on most days 
of a week because nuts are 
filling 
I should eat nuts on most days 
of a week because nuts are a 
good source of omega-3 fat 
48.2 
 
 
22.4 
 
 
28.2 
29.4 
 
 
25.9 
 
 
22.4 
10.6 
 
 
28.2 
 
 
38.8 
4.7 
 
 
10.6 
 
 
3.5 
3.5 
 
 
10.6 
 
 
2.4 
3.5 
 
 
2.4 
 
 
4.7 
 
Benefits & Barriers 
 The majority of participants neither agreed nor disagreed with the 17 benefit and barrier 
statements.  About 54% of participants strongly agreed or agreed with the benefit statement 
“Eating nuts on most days of a week would help me to eat more fiber.”  The majority (~53%) of 
participants strongly disagreed or disagreed with the barrier statement, “Eating nuts on most days 
of a week would cause me to eat too much fat” and “Eating nuts on most days of a week would 
cause me to eat too many calories.”  Approximately, 63.5% of participants indicated they 
strongly agreed or agreed with the statement, “I would eat nuts on most days of a week if my 
doctor recommended me to do so.”  Further results can be seen in Table 12. 
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Table 12. Distribution of statements concerning benefits and barriers to eating nuts on most days 
of a week 
Benefits and barrier statements 
1 
Strongly 
Agree 
2 
Agree 
3 
Neither 
4 
Disagree 
5 
Strongly 
Disagree 
Missing 
(%) (%) (%) (%) (%) (%) 
Benefits 
Eating nuts on most day of a  
week would help me feel better 
Eating nuts on most days of a 
week would help me to take better 
care of my body  
Eating nuts on most days of a 
week would help me get more 
nutrients 
Eating nuts on most days of a 
week would help me be healthier 
Eating nuts on most days of a 
week would give me the energy I 
need 
Eating nuts on most days of a 
week would help me to eat more 
fiber 
Eating nuts on most days of a 
week would help me to look 
young 
Eating nuts on most days of a 
week would be consistent with the 
advice of my doctor 
 
 
12.9 
 
20.0 
 
 
24.7 
 
 
25.9 
 
14.1 
 
 
29.4 
 
 
2.4 
 
 
15.3 
 
 
 
 
16.5 
 
23.5 
 
 
29.4 
 
 
27.1 
 
29.4 
 
 
27.1 
 
 
9.4 
 
 
11.8 
 
 
 
 
47.1 
 
36.5 
 
 
30.6 
 
 
32.0 
 
40.0 
 
 
29.4 
 
 
25.9 
 
 
42.4 
 
 
 
 
12.9 
 
9.4 
 
 
8.2 
 
 
7.1 
 
7.1 
 
 
7.1 
 
 
37.6 
 
 
12.9 
 
 
 
 
9.4 
 
9.4 
 
 
4.7 
 
 
5.9 
 
5.9 
 
 
3.5 
 
 
23.5 
 
 
15.3 
 
 
 
 
1.2 
 
1.2 
 
 
2.4 
 
 
1.2 
 
3.5 
 
 
3.6 
 
 
1.2 
 
 
2.4 
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Benefits and barrier statements 
1 
Strongly 
Agree 
2 
Agree 
3 
Neither 
4 
Disagree 
5 
Strongly 
Disagree 
Missing 
(%) (%) (%) (%) (%) (%) 
Barriers 
Eating nuts on most days of a 
week would cost me too much 
money  
Eating nuts on most days of a 
week would cause me to eat too 
much fat 
Eating nuts on most days of a 
week would cause me to eat too 
many calories  
I would eat nuts on most days of a 
week if they were available in 
grocery stores where I go 
shopping  
I would eat nuts on most days of a 
week if they were affordable 
I would eat nuts on most days of a 
week if they had more flavor 
I would eat nuts on most days of a 
week if they were lower in fat 
I would eat nuts on most days of a 
week if they were lower in 
calories 
I would eat nuts on most days of a 
week if my doctor recommended 
me to do so 
 
8.2 
 
 
12.9 
 
 
20.0 
 
 
17.6 
 
 
 
23.5 
 
8.2 
 
22.4 
 
25.9 
 
 
43.5 
 
16.5 
 
 
11.8 
 
 
12.9 
 
 
10.6 
 
 
 
20.0 
 
7.1 
 
11.8 
 
11.8 
 
 
20.0 
 
27.1 
 
 
20.0 
 
 
17.6 
 
 
29.4 
 
 
 
27.1 
 
27.1 
 
23.5 
 
27.1 
 
 
22.4 
 
23.5 
 
 
30.6 
 
 
25.9 
 
 
16.5 
 
 
 
9.4 
 
27.1 
 
17.6 
 
14.1 
 
 
2.4 
 
23.5 
 
 
22.4 
 
 
20.0 
 
 
22.4 
 
 
 
17.6 
 
25.9 
 
21.2 
 
18.8 
 
 
9.4 
 
1.2 
 
 
2.4 
 
 
3.5 
 
 
3.5 
 
 
 
2.4 
 
4.7 
 
3.5 
 
2.4 
 
 
2.4 
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Knowledge 
 An average of 61% of participants answered the knowledge questions concerning the 
nutrient content of tree nut and peanuts incorrectly. “Peanuts and walnuts are considered a good 
source of which of the following fats?” was the only exception; 65.9% answered correctly.  
Table 13 indicates the percent answered correctly by participants for all five knowledge 
questions. 
Table 13. Percentage of correctly answered knowledge questions related to the nutrient content 
of nuts 
Knowledge Questions 
Correct 
Answers 
(%) 
Missing 
(%) 
Nuts such as almonds, pecans, macadamia nuts, cashews and/or 
hazelnuts contain mainly which of the following type of fat?  
Walnuts contain mainly which of the following fat? 
Peanuts and walnuts are considered a good source of which of the 
following fats? 
Which of the following nuts have the highest content of omega-3 
fatty acids? 
Which of the following nuts have the highest content of selenium?  
14.1 
 
5.9 
65.9 
 
25.9 
 
22.4 
8.2 
 
8.2 
12.9 
 
10.6 
 
20.0 
 
Nut Consumption 
 Slightly more than half the participants believed they consumed a healthy diet (56.5%).  
However, only 35.3% indicated they ate nuts 1-2 times a week, as shown in Table 14.  Table 15 
shows that participants were more likely to consume salted nuts (55.3%) or roasted nuts (74.1%).  
Most individuals preferred peanuts, almonds, cashews, or pecans (72.9, 45.9, 42.4, 60.0; 
respectively). 
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Table 14. Percentage of nut intake 
Nut Intake Answer (%) 
Never 
Less than once a month 
1-2 times a month 
Once a week 
1-2 times a week 
Missing 
5.9 
16.5 
22.4 
18.8 
35.3 
1.2 
 
Table 15. Percentages related to nut consumption 
Nut Consumption Yes  
(%) 
No 
 (%) 
Missing 
(%) 
 I typically eat raw nuts 
I typically eat salted nuts 
I typically eat roasted nuts 
I typically eat nuts as nut butter 
I typically eat none of the above 
I would most likely eat raw nuts 
I would most likely eat salted nuts 
I would most likely eat roasted nuts 
I would most likely eat nuts as nut butter 
I would most likely not eat any of the above 
I consume peanuts more often 
I consume almonds more often 
I consume cashews more often 
I consume pine nuts more often 
I consume Brazil nuts more often 
I consume macadamia nuts more often 
I consume hazelnuts more often 
I consume pecans more often 
34.1 
55.3 
74.1 
17.6 
3.5 
22.4 
41.2 
63.5 
14.1 
2.4 
72.9 
45.9 
42.4 
3.5 
9.4 
8.2 
4.7 
60.0 
64.7 
43.5 
24.7 
81.2 
95.3 
76.5 
57.6 
35.3 
84.7 
96.5 
25.9 
52.9 
56.5 
95.3 
89.4 
90.6 
94.1 
38.8 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
1.2 
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Nut Consumption Yes  
(%) 
No 
 (%) 
Missing 
(%) 
I consume walnuts more often 
I consume pistachios more often 
36.5 
24.7 
62.4 
74.1 
1.2 
1.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CHAPTER 4: DISCUSSION 
A number of studies have shown that frequent nut intake can decrease the risk of chronic 
disease development, such as CVD or diabetes, in comparison to those with infrequent or no nut 
intake (Fraser et al., 1992; Kushi et al., 1996; Hu et al., 1998; Kelly & Sabaté, 2006; Albert et al., 
2002; Djoussé et al., 2008; Djoussé et al., 2009; Jiang et al., 2002; Villegas et al., 2008; 
Chisholm et al., 2005; Banel & Hu, 2009; Griel et al., 2008; Gebauer et al., 2008; Sabaté et al., 
2010; Rajaram et al., 2010; Jiang et al., 2006; Mantzoro et al., 2006).  Men as young as 35 to 44 
years of age and women in their mid fifties are at an increased risk for developing CVD (Rogers 
et al., 2011).  These individuals also have a greater chance of developing diabetes.  Therefore, it 
would be important that they not only be aware of the benefits associated with nut intake, but 
also understand the significance for following the recommendations for nut consumption. 
Unfortunately, no studies have been conducted to date that assessed individuals’ beliefs, 
perceptions (e.g. attitudes, perceived barriers and benefits), knowledge, and nut consumption 
among people with or at risk for developing these health conditions. Thus, the goal of this study 
was to fill this gap. Specifically, this research attempted to: 1) assess the salient beliefs, 2) 
measure positive and negative attitudes, 3) evaluate perceived benefits and barriers, and 4) assess 
knowledge, regarding the nutrient content and heath benefits associated with nut intake in 
individuals with or at risk for developing CVD and/or diabetes. Additionally, nut consumption 
was assessed. 
The current research revealed that the awareness of the nutritional content and health 
benefits of frequent nut consumption among the study sample, for the most part, was inadequate.  
Other studies have found similar results.  For instance, two-thirds of WIC participants did not 
believe nuts had hypocholesterolemic effects and only slightly more than one-third were aware 
 that nuts do not influence weight gain (Pawlak, Colby, & Herring, 2009).  A study conducted by 
Pawlak and colleagues (2009) found very similar results to the results of the current study when 
evaluating the beliefs, benefits, barriers, attitudes, and knowledge of nut consumption in a 
population of WIC participants.  Contrary results were reported in another study conducted by 
Pawlak (2009) that included registered dietitians.  In fact, the majority of the dietitians were 
aware of the hypocholesterolemic effects of nuts (Pawlak, 2009).  Pawlak (2009) found adequate 
beliefs, perceptions, and knowledge regarding the beneficial health effects and nutritional 
content of nuts among dietitians.  
The current research indicated that approximately, one-third of the participants were 
unaware that nuts could lower cholesterol levels and 21% believed they did not exhibit these 
effects.  Similar results were seen in individuals previously diagnosed with CVD.  This belief is 
inconsistent with recent studies; a meta-analysis conducted with Banel and Hu (2009) indicated 
that nut consumption does in fact lower blood lipid profiles.  About 40% of respondents were 
unaware and about 20% did not believe that nut consumption is beneficial in terms of prevention 
of diabetes and heart attacks. Among the 29 individuals previously diagnosed with diabetes, 
37.9% were also unaware and 10.3% did not believe that frequent nut intake could help decrease 
the risk of developing diabetes.  Also, out of the 46 individuals previously diagnosed with CVD, 
41.3% were unaware and 13% did not think that nuts have beneficial effects on heart attack risk.  
Individuals previously diagnosed with these health conditions seem to be more aware of the 
benefits of frequent nut consumption.   
About one-third of the participants strongly agreed, agreed or neither agreed nor 
disagreed with the negative attitudinal statement, “I should not eat nuts on most days of the week 
because I would gain weight.”  According to the Djoussé, Rudich, and Gaziano (2008) 
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participants who consumed nuts had lower weights in comparison to those with no nut intake.  
More individuals previously diagnosed with diabetes (44.8%) indicated they would eat nuts most 
days of the week if nuts contained lower amounts of fat in comparison to the entire study sample 
(34.2%).  Higher BMIs and obesity status are risk factors for CVD and diabetes. The results of 
this research study indicate that about one-third of participants in the current study were largely 
unaware of or held an incorrect belief about the impact of nuts on weight. Such an incorrect 
belief could be a barrier for nut consumption for these individuals.   
Interestingly, 65.9% of participants knew that peanuts and walnuts were a good source of 
omega-3 fatty acids and half of the participant either strongly agreed or agreed with the 
attitudinal statement, “I should eat nuts on most days of a week because nuts are a good source 
of omega-3 fat.”  This could explain why the intake of peanuts was higher than the intake of 
other nuts. However, it would not explain relatively low intake of walnuts. Thus, it is also 
possible that the relatively high intake of peanuts is a result of the popularity of peanut products 
such as peanut butter, irrespective of any health-related or nutritional content of peanuts.  Also, 
relatively low intake of walnuts could also be due to other barriers mentioned below.  The 
percentage of participants previously diagnosed with some type of CVD and/or diabetes rated the 
positive and negative attitudinal statements in a similar way, with the exception of the statement 
related to high fat content.   
About one-third of the participants answered neither agreed nor disagreed for many of the 
benefits questions, indicating that they are not aware of such benefits. Participants previously 
diagnosed with CVD also answered these statements similarly.  However, the awareness of the 
association of nuts intake on lower diabetes risk was higher among individuals previously 
diagnosed with diabetes than those who were not diagnosed with this disease (48% vs. 34%).  
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This indicates that individuals previously diagnosed with diabetes may be more aware of the 
benefits of nuts in diabetes prevention. 
Nut consumption among participants was relatively low.  Many individuals were aware 
of the high fat and calorie content in nuts, yet they were unaware of the beneficial impact these 
nutrients have on CVD and diabetes.  People are often cautious about calorie and fat intake, 
which could explain the low intake of nuts. On the other hand, studies have shown that the fiber 
content in nuts decreases the risk of developing CVD and diabetes (Sabaté & Ang, 2009).  Thus, 
one possible way to increase intake of nuts is to educate the public regarding the fiber content 
found in nuts.  
Only 27% of participants strongly agreed or agreed that their doctors advise them to eat 
nuts on most days of the week.  While the majority of participants strongly agreed or agreed that 
they would consume nuts on most days of the week if the doctor recommended them to do so.  
Higher proportion of participants with diabetes (65.5%) strongly agreed or agreed that they 
would consume nuts if recommended to do so by their doctor.  St. Michael’s Hospital and the 
University of Toronto conducted a study on the effects of doctor’s dietary advice on lowering 
cholesterol levels.  Participants given doctor’s advice had lowered cholesterol levels by about 
13%; while participants who did not receive advice only decreased cholesterol levels by 3%.  
Doctor’s dietary advice may be an effective, way to improve the health of individuals (Patients 
listens when doctors give dietary advice, 2011). Our study confirms this suggestion, since almost 
two/thirds indicated that they would follow such advice. However, it is unclear the extent of 
awareness among physicians regarding the effects of nuts on CVD and diabetes. Future studies 
are needed to assess physician awareness and recommendation practices.  
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Aside from doctor’s recommendation, nut affordability was the largest barrier indicated 
among the entire sample.  Slightly less than half of the participants indicated the affordability of 
nuts and about one-third implied that the nutrient content (calories and fat) of nuts were a barrier 
of nut consumption.  Individuals diagnosed with diabetes strongly agreed or agreed they would 
eat nuts if they were available in the grocery stores where they shopped (37.9%) in comparison 
to the study sample (28.2).  Individuals who were previously diagnosed with diabetes indicated 
flavor and fat content as a barrier to nut consumption (24.1% and 44.8%, respectively).   
 Participants’ level of knowledge regarding nutrient content of nuts was very low, an 
average of 61% of participants answered incorrect responses.  Only about one-eighth of the 
participants were aware of the predominant fat, MUFA, found in nuts and about one-fifth were 
aware of the selenium content in Brazil nuts.  About 68% of respondents reported they believed 
nuts were high in fat, and 56% believed they should not consume nuts due to this high content.  
However, nuts contain very beneficial types of fat, such as MUFA and PUFA, and are low in 
SFA (Chisholm, McAuley, Mann, Williams, & Skeaff, 2005; Ros 2010).  A higher volume of 
nuts consumption with beneficial MUFA and PUFA could replace those foods that are high in 
SFA (Griel et al., 2008).  An increased consumption of these beneficial fats in comparison to 
non-beneficial fats is in compliance to the 2010 Dietary Guidelines for Americans (Dietary 
guidelines for Americans 2010, 2010).   
Individuals previously diagnosed with one or more types of CVD, also incorrectly 
answered all the questions, an average of 61% of individuals with incorrect responses.  
Individuals previously diagnosed with diabetes indicated they had a slightly higher correct 
response percentage relating to the nutrient content of nuts in comparison to the study sample, 
averaging 55% of participants answered incorrectly.  This indicates that participants may not be 
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aware of the beneficial nutrients found in nuts and could explain the relatively low nut intake.  
However, individuals diagnosed with diabetes may have received some nutrition education. 
Only about one-third of the participants indicated they consume nuts 1-2 times a week. 
The majority of participants’ intake was less frequent. Thus, the majority of the participants 
failed to have an intake of nuts that reflects the current recommendation of 1.5 ounces on most 
days of the week.  At the same time, a little over half of the participant believed they consumed a 
healthy diet.  Beliefs regarding doctors’ advice/recommendations, affordability and fat and 
calorie content may play a significant role in low nut intake within this population.  Education 
and advice from doctors and other healthcare professionals communicating the current scientific 
evidence, regarding the health benefits of frequent nut intake on CVD and diabetes, could help 
increase nut consumption and awareness.  
 This is the only study to date, to assess beliefs, perceptions (e.g. attitudes, perceived 
barriers and benefits), knowledge, and nut consumption among people at risk for developing 
CVD and/or diabetes.  It is important for individuals over the age of 40 to be aware of the 
benefits nuts have on health conditions, since they are at greater risk for developing CVD and/or 
diabetes (Rogers et al., 2011).  Unfortunately, this study provides evidence that scientific 
knowledge on the health benefits of frequent nut consumption is not being communicated to 
individuals over the age of 40.  Pawlak, Colby, and Herring (2009) found that WIC participants 
are also largely unaware of current scientific findings regarding the health benefits due to 
frequent nut consumption.  Only three studies have been conducted on the beliefs, perceptions 
and knowledge on the beneficial health impact of nut consumption, including the current study.  
More studies are needed to determine the best way to address the gaps in awareness of 
individuals regarding nutrient profile and health effect of nuts intake.  
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Study Limitations 
There were two major limitations to the current research.  Only 85 participants were 
included in this study, creating a small sample size, and only Caucasian and African American 
ethnicities were included in the sample.  Additional studies need to be conducted to assess the 
most important factors influencing the intake of nuts in both the general public and people at risk 
for chronic health conditions.  Also studies on the best way to relay current scientific evidence to 
individuals and an evaluation of beliefs, perceptions, knowledge, and nut consumption 
differences between different health conditions need to be conducted. 
Conclusion 
Individuals over the age of 40 years are at an increased risk for developing CVD and/or 
diabetes (Rogers et al., 2011).  CVD and diabetes are among the leading causes of death in the 
United States.  Studies have shown that frequent nut consumption has an inverse association with 
CVD and diabetes incidences and mortalities.  This scientific evidence needs to be expressed 
more thoroughly to individuals over the age of 40 with or at risk for these health conditions.  
Many individuals were not aware that nuts could help lower the risk for a heart attack or diabetes 
and one-third believed nuts caused weight gain.  Beliefs and perceptions (attitudes, perceived 
barriers and benefits) were inadequate, while knowledge levels were very low regarding the 
health benefits and nutrient content of nut intake.  Individuals seek doctors for advice; therefore 
doctors play a key role in informing individuals of the health benefits regarding frequent nut 
intake (Patients listens when doctors give dietary advice, 2011).  Informing individuals over the 
age of 40 years, with or at risk for developing CVD and/or diabetes, about the health benefits of 
nut consumption may decrease CVD and/or diabetes incidences and mortalities. 
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To whom it may concern, 
  
I am happy to support Hilary London work toward the completion of her thesis here at 
HealthSteps.  She will be allowed to administer a survey to cardiovascular patients at 
HealthSteps and I will assist her as needed. 
  
Mary Tayloe Gaskins, MS, RD, LDN 
Clinical Dietitian III 
HealthSteps, Cardiovascular and Pulmonary Rehabilitation Program and 
The Heart Failure Clinic at HealthSteps 
P.O. Box 6028 
Greenville, NC 27835-6028 
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 APPENDIX C: CONSENT FORM & SURVEY 
 
March 3, 2011 
 
Hello, 
You are invited to take a part in a research study about perception, knowledge and beliefs 
on nut intake. If you agree to take part in this study you will agree to complete a survey 
administered to you by a health care professional/employee at your facility. The goal of this 
research is to find out consumers’ perception of eating nuts. Your participation is 
ABSOLUTELY voluntary and you may drop out or refuse to complete the survey at any time. 
There is virtually no risk of any kind to you as a participant. All collected data will be kept in a 
locked office and will not be used to discriminate against you or to cause you or anyone any 
harm. Collected data may be used in publications in professional journals; however, your name 
will never be used in any form in any reports based on this study. In fact, the survey you will be 
asked to complete is anonymous and thus, you will be asked not to sign or print your name on 
the survey. By completing the attached survey you indicate that you agree to participate in this 
study.   
Please note that this research has been approved by the Institutional Review Board at East 
Carolina University, which ensures that the rights of study participants are respected at all times. 
If you have any questions about this survey, the research project or your role as a participant, or 
if you have any other questions or concerns, please contact me at the address given below or 
speak to the health care professional/employee at the site.  
We sincerely appreciate your willingness to take part in this study. 
 
Regards,  
 
Hilary London,      Roman Pawlak, Ph. D 
Principal Investigator      Associate Professor 
Graduate Student     East Carolina University 
Department of Nutrition and Dietetics  Ph.: 252-328-2350 
East Carolina University  
207-943-3121 
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Nuts can be defined as seeds of some plants covered by hard, woody shell. Nuts are usually 
divided into two categories: tree nuts and peanuts. Tree nuts include almonds, Brazil nuts, 
cashews, chestnuts, coconuts, hazelnuts, macadamia nuts, pecans, pistachios and walnuts. Please 
answer each of the following questions about your perception of the health effects and nutrient 
content of nuts. 
I. Please circle the appropriate number that corresponds with your degree of agreement for 
each statement.  
  Agree        Disagree 
 1     2     3     4     5 
1 
2 
3 
 
4 
5 
6 
7 
8 
9 
10 
 
11 
12 
 
13 
14 
15 
16 
17 
18 
 
I should not eat nuts on most days of a week because they are high in fat  
I should not eat nuts on most days of a week because they are high in salt 
I should not eat nuts on most days of a week because they would cause 
my cholesterol to increase  
I should not eat nuts on most days of a week because I would gain weight 
I should not eat nuts on most days of a week because nuts cause allergies 
I should eat nuts on most days of a week because nuts are healthy ……… 
I should eat nuts on most days of a week because nuts are high in nutrients  
I should eat nuts on most days of a week because nuts are high in protein 
I should eat nuts on most days of a week because nuts are filling ……….. 
I should eat nuts on most days of a week because nuts are a good source 
of omega-3 fat 
Eating nuts on most day of a week would help me feel better ………….. 
Eating nuts on most days of a week would help me to take better care of 
my body  
Eating nuts on most days of a week would help me get more nutrients …. 
Eating nuts on most days of a week would help me be healthier …........... 
Eating nuts on most days of a week would give me the energy I need ….. 
Eating nuts on most days of a week would help me to eat more fiber …… 
Eating nuts on most days of a week would help me to look young ……… 
Eating nuts on most days of a week would be consistent with the advice of 
my doctor 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
 
1     2     3     4     5 
1     2     3     4     5 
 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
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  Agree        Disagree 
 1     2     3     4     5 
19 
20 
21 
 
22 
 
23 
24 
25 
26 
27 
 
Eating nuts on most days of a week would cost me too much money …… 
Eating nuts on most days of a week would cause me to eat too much fat … 
Eating nuts on most days of a week would cause me to eat too many 
calories  
I would eat nuts on most days of a week if they were available in grocery 
stores where I go shopping  
I would eat nuts on most days of a week if they were affordable ……….. 
I would eat nuts on most days of a week if they had more flavor ………... 
I would eat nuts on most days of a week if they were lower in fat ………. 
I would eat nuts on most days of a week if they were lower in calories …. 
I would eat nuts on most days of a week if my doctor recommended me to 
do so 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
 
1     2     3     4     5 
 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
1     2     3     4     5 
 
II. Please place a check “√” in an appropriate column. 
  True/ 
Agree 
False/ 
Disagree 
I 
don’t  
know 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Nuts are high in calories ………………………………………... 
Nuts are high in fat ……………………………………………... 
Nuts are high in dietary fiber …………………………………... 
Nuts are high in salt ……………………………………………. 
Eating nuts may help to lower cholesterol level ……………….. 
Eating nuts may help to lower a risk for a heart attack ………… 
Eating nuts may help to lower a risk for diabetes ……………… 
Eating nuts will cause weight gain ……………………………... 
The U.S. Food and Drug Administration approved a health 
claim to say that eating nuts daily/on most days may lower 
cholesterol and prevent heart disease 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
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III. Please select the answer you believe is correct for each question.  
1. Nuts such as almonds, pecans, macadamia nuts, cashews and/or hazelnuts contain 
mainly which of the following type of fat?  
a. Saturated fat 
b. Monounsaturated fat 
c. Polyunsaturated fat 
d. Omega-3 fat  
2. Walnuts contain mainly which of the following fat? 
a. Saturated fat 
b. Monounsaturated fat 
c. Polyunsaturated fat 
d. I don’t know  
3. Peanuts and walnuts are considered a good source of which of the following fats? 
a. Arachidonic acid 
b. Omega-3 fatty acids 
c. Omega-6 fatty acids 
d. EPA 
e. DHA 
4. Which of the following nuts have the highest content of omega-3 fatty acids? 
a. Almonds   b. Brazil nuts 
c. Cashews    d. Hazelnuts  
e. Macadamia nuts  f. Pecans  
g. Peanut    h. Walnuts  
 
5. Which of the following nuts have the highest content of selenium?  
a. Almonds   b. Brazil nuts 
c. Cashews    d. Hazelnuts  
e. Macadamia nuts  f. Pecans  
      g. Peanut    h. Walnuts  
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IV. Please answer the following questions that deal with the consumption of nuts.  
 
1. Which of the following nuts do you typically eat, if any? (select all that you eat) 
a. Raw 
b. Salted 
c. Roasted  
d. As nut butter  
e. None 
2. If you were to eat nuts, which of the following nuts you would most likely eat? (select one) 
a. Raw 
b. Salted 
c. Roasted  
d. As nut butter  
e. None 
3. Which of the following nuts do you consume most often? (select all that you eat)
⁭ Peanuts 
⁭ Almonds 
⁭ Cashews 
⁭ Pine Nuts 
⁭ Brazil Nuts 
⁭ Macadamia Nuts 
⁭ Hazelnuts 
⁭ Pecans 
⁭ Walnuts 
⁭ Pistachios
4. How often do you consume nut 
⁭ Never 
⁭ Less than once a month 
⁭ 1-2 times a month 
⁭ Once a week 
⁭ 1-2 times a week
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V. Please complete the information found below. This section will only be used to describe 
the group of people who completed the survey. Your personal characteristics will not be 
revealed.  
 
1.  I am a  Male Female  
 
2.  I am ______ years old.  
 
3. My height is ___ feet and ___ inches and my weight is ______ lbs. 
 
4. My ethnic background is: 
a. African American           c. Asian American   e. Caucasian (White)        
b. Hispanic American  d. Native American      f. Other (specify): 
 
5. My annual household income is: 
a. Less than 10,000  d. 35,001-50,000   f. 65,001-85,000 
b. 10,000 -20,000   e. 50,001-65,000   g. 85,000 or more 
c. 20,001-35,000  
 
 6. My highest attained level of education is: 
a.  Less than high school         
b.  Graduated from high school or completed the GED 
c.  Some college 
d.  Graduated from college  
 
7. Do you believe you have a healthy diet? 
a. Yes, I have a healthy diet. 
b. No, I do not have a healthy diet. 
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8.  Have you ever been diagnosed with any of the following (mark and fill in all that apply)? 
Disease Yes No I do not remember/ 
I do not know 
Age Diagnosed 
Heart disease 
Angina 
Hypertension 
High cholesterol 
Diabetes 
⁭ 
⁭ 
⁭ 
⁭ 
⁭ 
⁭ 
⁭ 
⁭ 
⁭ 
⁭ 
⁭ 
⁭ 
⁭ 
⁭ 
⁭ 
 
 
Thank you for completing the survey! 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
